Unraveling epigenetic heterogeneity across gastrointestinal adenocarcinomas through a standardized analytical framework
Molecular Oncology · 2025-04 · 19 (4) · 1117-1131
DOI: 10.1002/1878-0261.13772 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Oncology, online erschienen am 18.12.2024. Verfasst von Rita Pinto und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital - Norwegian Radium Hospital, Oslo, Norway. Hauptthemen laut MEDLINE: Adenocarcinoma, Gastrointestinal Neoplasms, Epigenesis, Genetic, Genetic Heterogeneity. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kreftforeningen, Helse Sør-Øst RHF.
Abstract (Originalsprache)
In this study, we propose an alternative approach for stratifying genome‐scale DNA methylation profiles of gastrointestinal (GI) adenocarcinomas based on a robust analytical framework. A set of 978 GI adenocarcinomas and 120 adjacent normal tissues from public repositories was quality controlled and analyzed. Hierarchical consensus clustering of the tumors, based on differential epigenetic variability between malignant and normal samples, identified six distinct subtypes defined either by a pan‐GI or a lower GI‐specific phenotype. In addition to methylation levels, aberrant methylation frequencies and the degree of DNA methylation instability contributed to the characterization of each subtype. We found significant differences in the outcome of patients, with the poorest overall survival seen for those belonging to a pan‐GI subtype with infrequent aberrant methylation. In conclusion, our standardized approach contributes to a refined characterization of the epigenetic heterogeneity in GI adenocarcinomas, offering insights into subtype‐specific methylation with the potential to support prognostication.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital - Norwegian Radium Hospital, Oslo, Norway.
- Department of Biosciences, The Faculty of Mathematics and Natural Sciences, University of Oslo, Norway.
ORCID-Profile: Rita Pinto, Guro Elisabeth Lind
Förderung
- Kreftforeningen
- Helse Sør-Øst RHF
Zitieren
APA
Pinto, R., Vedeld, H. M., Lind, G. E., & Jeanmougin, M. (2025). Unraveling epigenetic heterogeneity across gastrointestinal adenocarcinomas through a standardized analytical framework. Molecular Oncology, 19(4), 1117-1131. https://doi.org/10.1002/1878-0261.13772
Vancouver
Pinto R, Vedeld HM, Lind GE, Jeanmougin M. Unraveling epigenetic heterogeneity across gastrointestinal adenocarcinomas through a standardized analytical framework. Molecular Oncology. 2025;19(4):1117-1131. doi:10.1002/1878-0261.13772
BibTeX
@article{Pinto2025,
author = {Pinto, Rita and Vedeld, Hege Marie and Lind, Guro Elisabeth and Jeanmougin, Marine},
title = {Unraveling epigenetic heterogeneity across gastrointestinal adenocarcinomas through a standardized analytical framework},
journal = {Molecular Oncology},
year = {2025},
volume = {19},
number = {4},
pages = {1117--1131},
doi = {10.1002/1878-0261.13772}
}
EUVIMED